Back to Lung Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT02810262

NCT02810262
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are 18 years old or older
  • You can be either male or female
  • You are covered by French National Health Insurance
  • You have been diagnosed with bone metastases (cancer that has spread to the bones) for the first time, caused by a type of lung cancer called adenocarcinoma (this can be either at the same time as the original diagnosis or discovered later)

Who may not be able to join:

  • You have already received any systemic treatment for your adenocarcinoma lung cancer, such as chemotherapy, targeted therapy, or immunotherapy (treatments that work throughout the whole body)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Hospices Civils de Lyon
Registry
clinicaltrials_gov
Start date
1 June 2011
Est. completion
1 December 2019

Where this trial is recruiting

🇫🇷 France

Primary endpoints

serum DKK1

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov